-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Hormone Sensitive Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PM-534 in Hormone Sensitive Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Hormone Sensitive Breast Cancer Drug Details: PM-534 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PM-534 in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Castration-Resistant Prostate Cancer (CRPC) Drug Details: PM-534 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-1015 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PM-1015 in Solid Tumor Drug Details: PM-1015 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Solid Tumor Drug Details: PM-534 is under development for the treatment of advanced...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Paclitaxel in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel in Cervical Cancer Drug Details: Paclitaxel (Genexol-PM) belongs to the class...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Paclitaxel in Bile Duct Cancer (Cholangiocarcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Bile Duct Cancer (Cholangiocarcinoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paclitaxel in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: Paclitaxel (Genexol-PM)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Plocabulin in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plocabulin in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plocabulin in Non-Small Cell Lung Cancer Drug Details: Plocabulin (PM-184,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Plocabulin in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plocabulin in Cervical Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plocabulin in Cervical Cancer Drug Details: Plocabulin (PM-184, PM-060184) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plocabulin in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plocabulin in Head And Neck Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plocabulin in Head And Neck Cancer Drug Details: Plocabulin (PM-184,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plocabulin in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plocabulin in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plocabulin in Endometrial Cancer Drug Details: Plocabulin (PM-184, PM-060184) is under development...